• Andrew Notarianni and Bhoumesh Patel.
• Division of Cardiac Anesthesiology, Department of Anesthesiology, Yale School of Medicine, New Haven, Connecticut, USA.
• Curr Opin Anaesthesiol. 2022 Feb 1; 35 (1): 105108105-108.

Purpose Of ReviewThe use of mechanical circulatory support (MCS) devices, such as left ventricular assist device and extracorporeal membrane oxygenation in the elderly have been rapidly increasing in various clinical settings over the past two decades. This review briefly summarizes recent literature on the role and outcomes of such mechanical circulatory support devices use in the elderly.Recent FindingsElderly patients are receiving increasing number of LVADs with improved survival and quality-of-life outcomes, despite multiple comorbidities. ECMO is a viable option in elderly patients but they have a higher risk of mortality after both VA ECMO and VV ECMO support. However, comorbidities, clinical presentation and timing of ECMO initiation seems to have a greater impact on prognosis than for younger patients.SummaryMCS device use continue to rise in the elderly population. Meticulously selected elderly patients could be successfully supported with MCS devices with favorable outcomes and acceptable mortality and complication rate.Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

7 keywords...

hide…